NDC product
up and up nighttime flu and severe cold and cough
NDC 11673-113 · Target Corporation
Key facts
| Product NDC | 11673-113 |
|---|---|
| Proprietary name | up and up |
| Nonproprietary name | Acetaminophen, Diphenhydramine hydrochloride, and Phenylephrine hydrochloride |
| Substances | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Jun 28, 2013 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: